The first FDA-cleared chest X-ray CAD system to assist in detecting early-stage lung cancer, RapidScreen is designed to quickly identify solitary pulmonary nodules between 9 and 30 mm and other suspicious nodules on the original standard AP/PA chest X-ray, providing a virtual second pair of eyes for the radiologist. The system offers film and filmless solutions as well as an upgrade path for those seeking to evolve to filmless in the future.
June 6, 2023 — RaySearch Laboratories has announced that New York University (NYU) Langone Hospital - Long Island ...
June 06, 2023 
January 18, 2023 — Addressing the growing demand for medical imaging and a shortage of radiologists, Bayer announced the ...
January 18, 2023 
December 14, 2022 — Dallas, TX-based MedCognetics, Inc. announced it has received U.S Food and Drug Administration (FDA) ...
December 14, 2022 
November 25, 2022 — Hologic, Inc. will exhibit its extensive portfolio of breast and skeletal health products at the ...
November 25, 2022 
September 13, 2022 — Deciphex, a Dublin, Ireland-based provider of digital pathology software and services, has ...
September 13, 2022 
December 1, 2020 – Medical imaging artificial intelligence (AI) vendor Avicenna.AI today announced its FDA-cleared CINA ...
December 01, 2020 
February 7, 2020 – At the 2019 Radiological Society of North America (RSNA) meeting in December, there was a record ...
February 07, 2020 
January 22, 2020 — The U.S. Food and Drug Administration (FDA) has issued a final order to reclassify medical image ...
January 22, 2020 
October 31, 2019 — Zebra Medical Vision, a deep learning medical imaging analytics company, announced this week a ...
October 31, 2019 
October 28, 2019 — Artificial intelligence (AI) helps improve the efficiency and accuracy of an advanced imaging ...
October 28, 2019